Clinical trial
S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating…
NCT00040937 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00040937 |
|---|---|
| Title | S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma |
| Official title | A Phase II Trial Of Thalidomide/Dexamethasone Induction Followed By Tandem Melphalan Transplant And Prednisone/Thalidomide Maintenance (A BMT Study) |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, sargramostim, cyclophosphamide, dexamethasone, melphalan, prednisone, thalidomide, peripheral blood stem cell transplantation |
| Enrollment | 147 |
| Start date | Jun 1, 2002 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2015 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 8, 2016 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: